Dr. Jordan RoseFigura from Swift Biosciences will present on the technology created to enable this research that covers 99.7 % of the SARS-CoV-2 genome from limited viral titers. Including an overview of the elegant SNAP workflow, sophisticated primer design, data anaylsis workflow, as well as, how targeted pathogen sequencing can enable variant detection in S Gene dropouts in COVID-19 Samples. Learn how adding Swift Normalase® can save costs and time in order to scale large studies.